Activating mutations of the stimulatory G protein in juvenile ovarian granulosa cell tumors: A new prognostic factor?

Journal of Clinical Endocrinology and Metabolism

Volumn 91, Issue 5, 2006, Pages 1842-1847

  Kalfa, Nicolas ^a,b,c   Ecochard, Aude ^a,b   Patte, Catherine ^d   Duvillard, Pierre ^d   Audran, Francoise ^a,b   Pienkowski, Catherine ^e   Thibaud, Elisabeth ^f   Brauner, Raja ^g   Lecointre, Claudine ^h   Plantaz, Dominique ⁱ   Guedj, Anne Marie ^j   Paris, Francoise ^a,b   Baldet, Pierre ^b   Lumbroso, Serge ^a,b,c,j   Sultan, Charles ^a,b,c,k  

^a HÔPITAL ARNAUD DE VILLENEUVE   (France)

^b LAPEYRONIE HOSPITAL   (France)

^c INSERM   (France)

^d INSTITUT GUSTAVE ROUSSY   (France)

^e HÔPITAL DES ENFANTS   (France)

^f HÔPITAL NECKER ENFANTS MALADES   (France)

^g BICÊTRE HOSPITAL   (France)

^h HÔPITAL CHARLES NICOLLE   (France)

ⁱ GRENOBLE UNIVERSITY HOSPITAL   (France)

^j DEPARTMENT OF NEUROLOGY   (France)

^k MONTPELLIER UNIVERSITY HOSPITAL   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ISOLATION; DNA SEQUENCE; GENE MUTATION; GERM CELL TUMOR; GRANULOSA CELL TUMOR; HUMAN; INFANT; MUTATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

CELL PROLIFERATION; CHILD; CHILD, PRESCHOOL; DNA; DNA MUTATIONAL ANALYSIS; FEMALE; GRANULOSA CELL TUMOR; GTP-BINDING PROTEIN ALPHA SUBUNITS, GS; HUMANS; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PARAFFIN EMBEDDING; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 33646410139     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2005-2710     Document Type: Article

References (43)

1. Young RH, Scully RE 1992 Endocrine tumors of the ovary. Curr Top Pathol 85:113-164
2. Scully RE 1995 Ovarian tumors with endocrine manifestations. In: DeGroot LJ, ed. Endocrinology. Philadelphia: Saunders; 2113-2139
3. Young RH, Dickersin GR, Scully RE 1984 Juvenile granulosa cell tumor of the ovary. A clinicopathological analysis of 125 cases. Am J Surg Pathol 8:575-596
4. Kalfa N, Patte C, Orbach D, Lecointre C, Pienkowski C, Philippe F, Thibault E, Plantaz D, Brauner R, Rubie H, Guedj AM, Ecochard A, Paris F, Jeandel C, Baldet P, Sultan C 2005 A nationwide study of granulosa cell tumors in preand postpubertal girls: missed diagnosis of endocrine manifestations worsens prognosis. J Pediatr Endocrinol Metab 18:25-31
5. Rossing MA, Weiss NS 1995 Fertility drugs and breast and ovarian cancer. Lancet 346:1627-1628
6. Mayr D, Kaltz-Wittmer C, Arbogast S, Amann G, Aust DE, Diebold J 2002 Characteristic pattern of genetic aberrations in ovarian granulosa cell tumors. Mod Pathol 15:951-957
7. Van den Berghe I, Dal Cin P, De Groef K, Michielssen P, Van den Berghe H 1999 Monosomy 22 and trisomy 14 may be early events in the tumorigenesis of adult granulosa cell tumor. Cancer Genet Cytogenet 112:46-48
8. Vassal G, Flamant F, Caillaud JM, Demeocq F, Nihoul-Fekete C, Lemerle J 1988 Juvenile granulosa cell tumor of the ovary in children: a clinical study of 15 cases. J Clin Oncol 6:990-995
9. Fuller PJ, Verity K, Shen Y, Mamers P, Jobling T, Burger HG 1998 No evidence of a role for mutations or polymorphisms of the follicle-stimulating hormone receptor in ovarian granulosa cell tumors. J Clin Endocrinol Metab 83:274-279
10. Graves PE, Surwit EA, Davis JR, Stouffer RL 1985 Adenylate cyclase in human ovarian cancers: sensitivity to gonadotropins and nonhormonal activators. Am J Obstet Gynecol 153:877-882
11. Amsterdam A, Selvaraj N 1997 Control of differentiation, transformation, and apoptosis in granulosa cells by oncogenes, oncoviruses, and tumor suppressor genes. Endocr Rev 18:435-461
12. Fuller PJ, Chu S, Jobling T, Mamers P, Healy DL, Burger HG 1999 Inhibin subunit gene expression in ovarian cancer. Gynecol Oncol 73:273-279
13. Chu S, Rushdi S, Zumpe ET, Mamers P, Healy DL, Jobling T, Burger HG, Fuller PJ 2002 FSH-regulated gene expression profiles in ovarian tumours and normal ovaries. Mol Hum Reprod 8:426-433
14. Healy DL, Burger HG, Mamers P, Jobling T, Bangah M, Quinn M, Grant P, Day AJ, Rome R, Campbell JJ 1993 Elevated serum inhibin concentrations in postmenopausal women with ovarian tumors. N Engl J Med 329:1539-1542
15. Kotlar TJ, Young RH, Albanese C, Crowley Jr WF, Scully RE, Jameson JL 1997 A mutation in the follicle-stimulating hormone receptor occurs frequently in human ovarian sex cord tumors. J Clin Endocrinol Metab 82:1020-1026
16. Fragoso MC, Latronico AC, Carvalho FM, Zerbini MC, Marcondes JA, Araujo LM, Lando VS, Frazzatto ET, Mendonca BB, Villares SM 1998 Activating mutation of the stimulatory G protein (gsp) as a putative cause of ovarian and testicular human stromal Leydig cell tumors. J Clin Endocrinol Metab 83:2074-2078
17. Ligtenberg MJ, Siers M, Themmen AP, Hanselaar TG, Willemsen W, Brunner HG 1999 Analysis of mutations in genes of the follicle-stimulating hormone receptor signaling pathway in ovarian granulosa cell tumors. J Clin Endocrinol Metab 84:2233-2234
18. Chien J, Wong E, Nikes E, Noble MJ, Pantazis CG, Shah GV 1999 Constitutive activation of stimulatory guanine nucleotide binding protein (G(S)αQL)-mediated signaling increases invasiveness and tumorigenicity of PC-3M prostate cancer cells. Oncogene 18:3376-3382
19. Benedet JL, Bender H, Jones H, 3rd, Ngan HY, Pecorelli S 2000 FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70:209-262
20. Tanner JM, Whitehouse RH 1976 Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51:170-179
21. Spiegel A, Shenker A, Simonds W, Weinstein L 1995 G protein dysfunction in disease. In: Weintraub B, ed. Molecular endocrinology: basic concepts and clinical correlations. New York: Raven Press; 297-318
22. Candeliere GA, Roughley PJ, Glorieux FH 1997 Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in Gαs from patients with fibrous dysplasia of bone. Bone 21:201-206
23. Lumbroso S, Paris F, Sultan C 2004 Activating Gsα mutations: analysis of 113 patients with signs of McCune-Albright syndrome: a European Collaborative Study. J Clin Endocrinol Metab 89:2107-2113
24. Schutze K, Lahr G 1998 Identification of expressed genes by laser-mediated manipulation of single cells. Nat Biotechnol 16:737-742
25. Chu S, Mamers P, Burger HG, Fuller PJ 2000 Estrogen receptor isoform gene expression in ovarian stromal and epithelial tumors. J Clin Endocrinol Metab 85:1200-1205
26. Kotlar T, Young RH, Albanese C, Crowley Jr WF, Scully RE, Jameson JL 1998 Absence of mutations in the FSH receptor in ovarian granulosa cell tumors. J Clin Endocrinol Metab 83:3001
27. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtinger H, Duh QY, Clark OH, Kawasaki E, Bourne HR, McCormick F 1990 Two G protein oncogenes in human endocrine tumors. Science 249:655-659
28. Tordjman K, Stern N, Ouaknine G, Yossiphov Y, Razon N, Nordenskjold M, Friedman E 1993 Activating mutations of the Gs α-gene in nonfunctioning pituitary tumors. J Clin Endocrinol Metab 77:765-769
29. Shen Y, Mamers P, Jobling T, Burger HG, Fuller PJ 1996 Absence of the previously reported G protein oncogene (gip2) in ovarian granulosa cell tumors. J Clin Endocrinol Metab 81:4159-4161
30. Hannon TS, King DW, Brinkman AD, Steinmetz R, Davis MM, Eugster EA, Pescovitz OH 2002 Premature thelarche and granulosa cell tumors: a search for FSH receptor and G5α activating mutations. J Pediatr Endocrinol Metab 15 (Suppl 3):891-895
31. Regnauld K, Nguyen QD, Vakaet L, Bruyneel E, Launay JM, Endo T, Mareel M, Gespach C, Emami S 2002 G-protein α(olf) subunit promotes cellular invasion, survival, and neuroendocrine differentiation in digestive and urogenital epithelial cells. Oncogene 21:4020-4031
32. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE, Graybiel AM 1998 A family of cAMP-binding proteins that directly activate Rap1. Science 282:2275-2279
33. de Rooij J, Rehmann H, van Triest M, Cool RH, Wittinghofer A, Bos JL 2000 Mechanism of regulation of the Epac family of cAMP-dependent RapGEFs. J Biol Chem 275:20829-20836
34. Reedquist KA, Ross E, Koop EA, Wolthuis RM, Zwartkruis FJ, van Kooyk Y, Salmon M, Buckley CD, Bos JL 2000 The small GTPase, Rap1, mediates CD31-induced integrin adhesion. J Cell Biol 148:1151-1158
35. Shaw LM 2001 Identification of insulin receptor substrate 1 (IRS-1) and IRS-2 as signaling intermediates in the α6β;4 integrin-dependent activation of phosphoinositide 3-OH kinase and promotion of invasion. Mol Cell Biol 21:5082-5093
36. Schneider DT, Janig U, Calaminus G, Gobel U, Harms D 2003 Ovarian sex cord-stromal tumors: a clinicopathological study of 72 cases from the Kiel Pediatric Tumor Registry. Virchows Arch 443:549-560
37. Schumer ST, Cannistra SA 2003 Granulosa cell tumor of the ovary. J Clin Oncol 21:1180-1189
38. Schneider DT, Calaminus G, Harms D, Gobel U 2005 Ovarian sex cordstromal tumors in children and adolescents. J Reprod Med 50:439-446
39. Lane AH, Lee MM, Fuller Jr AF, Kehas DJ, Donahoe PK, MacLaughlin DT 1999 Diagnostic utility of Mullerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors. Gynecol Oncol 73:51-55
40. Burger HG, Fuller PJ, Chu S, Mamers P, Drummond A, Susil B, Neva P, Robertson DM 2001 The inhibins and ovarian cancer. Mol Cell Endocrinol 180:145-148
41. Singh-Ranger G, Sharp A, Crinnion JN 2004 Recurrence of granulosa cell tumour after thirty years with small bowel obstruction. Int Semin Surg Oncol 1:4
42. East N, Alobaid A, Goffin F, Ouallouche K, Gauthier P 2005 Granulosa cell tumour: a recurrence 40 years after initial diagnosis. J Obstet Gynaecol Can 27:363-364
43. Coutant R, Lumbroso S, Rey R, Lahlou N, Venara M, Rouleau S, Sultan C, Limal JM 2001 Macroorchidism due to autonomous hyperfunction of Sertoli cells and G(s)α gene mutation: an unusual expression of McCune-Albright syndrome in a prepubertal boy. J Clin Endocrinol Metab 86:1778-1781